Filing Details

Accession Number:
0001209191-21-034235
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-19 20:00:19
Reporting Period:
2021-05-18
Accepted Time:
2021-05-19 20:00:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478320 Adaptive Biotechnologies Corp ADPT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1229765 Renee Michelle Griffin C/O Adaptive Biotechnologies Corp.
Suite 200
Seattle WA 98102
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-18 2,500 $7.80 4,004 No 4 M Direct
Common Stock Disposition 2021-05-18 2,500 $35.00 1,504 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-18 2,500 $0.00 2,500 $7.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
76,000 2029-04-23 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020.
  2. The options vested with respect to 1/4 of such shares on March 28, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.